Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and immunogenicity of AV7909 anthrax vaccine in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• AV7909

Snippet

Sponsor: Emergent BioSolutions | Conditions: Bacillus Anthracis (Anthrax) Infection | Phase 1 | Status: COMPLETED | Results posted: 2014-08-20